로딩 중…
지수 로딩 중…
Seoul Pharma Co., Ltd
018680· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,085-8.35%
2026-06-19
Price Chart
Seoul Pharma Co., Ltd-39.12%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 24.31B KRW |
| Revenue | 51.33B KRW |
| Net Income | -403.4M KRW |
| Total Assets | 70.77B KRW |
| Net Assets | 40.86B KRW |
| Employees | 176 |
| Value | |
| P/B | 0.59x |
| P/S | 0.47x |
| FCF Yield | 4.21% |
| Profitability | |
| ROE | -0.99% |
| ROA | -0.57% |
| Op. Margin | -0.56% |
| Revenue Growth | -6.38% |
| Earnings Growth | -156.82% |
| Financial Health | |
| Debt Ratio | 173.21% |
| Total Debt | 15.00B KRW |
| FCF | 1.02B KRW |
| Cash | 18.13B KRW |
| Current Ratio | 2.38x |
| Dividend | |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -39.12% |
| 1M Return | -20.11% |
| From 52W High | -42.00% |
| 1Y MDD | -41.59% |
| Trading | |
| Volume | 41,771 shares |
| Foreign Own. | 1.97% |
| Per Share | |
| EPS | 62 KRW |
| BPS | 3,504 KRW |
Company Info
Established in 1985 and listed on KOSDAQ in 2000, this pharmaceutical company produces drugs such as antihypertensive Ator, stroke treatment Plavel, and obesity treatment Weltmin. It leverages SmartFilm® Technology for oral disintegrating film manufacturing, supplying products to partners like Pfizer Korea. The company is preparing new and generic drugs for chronic diseases like hyperlipidemia, gastroesophageal reflux disease, and diabetes to expand market share, with its new Osong plant establishing a foundation for global expansion. Seoul Pharma is headquartered in Cheongju-si, Chungcheongbuk-do.